has tirzepatide been approved by the fda Says Compounded Must Exit Market FDA approves new weight-loss drug
Description
PGC: OR = 0.71, 95% CI [0.580.87]

2030 485( 706000)
However, the medication's effect on gastric emptying may make some individuals more sensitive to high-fat foods like cheese, potentially causing nausea or discomfort

Improvements in metabolic health and caloric restriction can reconstruct the gut microbiome [9]

Semaglutide and tirzepatide are available now, while retatrutide remains in trials, so the practical comparison for most patients today is between the two approved options
